HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer.

about

The role of neratinib in HER2-driven breast cancer.Recent Advances in Comprehending the Signaling Pathways Involved in the Progression of Breast Cancer.Genomic alterations of ERBB receptors in cancer: clinical implications.Activating HER2 mutations as emerging targets in multiple solid cancers.

P2860

Q38664492-7A025004-7669-4336-8E87-80E1DDD56474 Q47143199-36B04B52-3023-48D1-93C9-3CD8E0BE4FF6 Q49678076-E5D82ECB-9860-489D-85D2-798AFB9515F5 Q54986604-0AD689C3-166F-462A-BDCC-10F6316F2D42

P2860

HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer.

Item

http://www.wikidata.org/entity/Q38704133

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

HER2 Reactivation through Acqu ...... herapy in HER2+ Breast Cancer.

@en

type

Item

label

HER2 Reactivation through Acqu ...... herapy in HER2+ Breast Cancer.

@en

prefLabel

HER2 Reactivation through Acqu ...... herapy in HER2+ Breast Cancer.

@en

P1476

HER2 Reactivation through Acqu ...... herapy in HER2+ Breast Cancer.

@en

P2093

Agostina Nardone

http://www.w3.org/2001/XMLSchema#string

Alexander Renwick

http://www.w3.org/2001/XMLSchema#string

Ben H Park

http://www.w3.org/2001/XMLSchema#string

Britta Weigelt

http://www.w3.org/2001/XMLSchema#string

C Kent Osborne

http://www.w3.org/2001/XMLSchema#string

Carolina Gutierrez

http://www.w3.org/2001/XMLSchema#string

Chad A Shaw

http://www.w3.org/2001/XMLSchema#string

Chandandeep Nagi

http://www.w3.org/2001/XMLSchema#string

Daniel J Zabransky

http://www.w3.org/2001/XMLSchema#string

Edward S Chen

http://www.w3.org/2001/XMLSchema#string

P2860

VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing

Fast and accurate short read alignment with Burrows-Wheeler transform

TopHat: discovering splice junctions with RNA-Seq

Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blocker

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Lapatinib plus capecitabine for HER2-positive advanced breast cancer.

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.

Trastuzumab emtansine for HER2-positive advanced breast cancer.

Activating HER2 mutations in HER2 gene amplification negative breast cancer

P304

5123-5134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-16-2191

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Charlotte K Y Ng

Jamunarani Veeraraghavan

Ian G Waters

Carmine De Angelis

Vidyalakshmi Sethunath

P577

2017-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28487443

http://www.w3.org/2001/XMLSchema#string

P932

5762201

http://www.w3.org/2001/XMLSchema#string

HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer.

about

P2860

P2860

HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932